Kinnos
Brooklyn, US · Founded 2014 · 2 known investors
Find your way into Kinnos
541 people in our graph share verified history with the Kinnos team — schools, employers, funds. One of them is your warm intro.
Ben Robbinsunlockedknows Kevin Tyan · together at Massachusetts General Hospital
×2knows the team · via Dana-Farber Cancer Institute
knows the team · via Columbia University Medical Center - Clynes Lab
×5knows the team · via Massachusetts General Hospital
×3knows the team · via National Institutes of Health - Trepel Lab
Kinnos makes Highlight, a colorant additive for disinfectant wipes that provides real-time visual feedback on surface coverage and cleaning technique to healthcare facilities. The technology helps staff and facilities improve disinfection effectiveness and consistency without changing existing cleaning workflows.
Founders & leadership
Kinnos was founded in 2014 by Jason Kang, Kevin Tyan, and Katherine Jin.
Investors · 2
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 4 rounds · 2017–2022
▶$5.5MraisedNov 2022 · 26 investors · Other Health CareRule 506(b)
▶$5.5MraisedNov 2022 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric StoneDirector
- Robert ZollarsDirector
- Jason KangExecutive Officer, Director
- Katherine JinExecutive Officer
- Sherman LeeExecutive Officer
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedNov 2022 · 30 investors · Other Health CareRule 506(b)
▶$4.5MraisedNov 2022 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- KATHERINE JINExecutive Officer
- SHERMAN LEEExecutive Officer
- ROBERT ZOLLARSDirector
- ERIC STONEDirector
- JASON KANGExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $4.5M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedMar 2020 · 21 investors · Other Health CareRule 506(b)
▶$6.3MraisedMar 2020 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William GinsbergDirector
- Robert RosenbergDirector
- Shawn MarcellDirector
- Kevin TyanExecutive Officer
- Katherine JinExecutive Officer, Director
- Jason KangExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedMar 2017 · 13 investors · Other Health CareRule 506(b)
▶$1MraisedMar 2017 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KangExecutive Officer
- Kevin TyanExecutive Officer
- Katherine JinExecutive Officer
- Amount sold
- $1M
- Minimum investment
- $10K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Kinnos do?
- Kinnos makes Highlight, a colorant additive for disinfectant wipes that provides real-time visual feedback on surface coverage and cleaning technique to healthcare facilities. The technology helps staff and facilities improve disinfection effectiveness and consistency without changing existing cleaning workflows.
- Who founded Kinnos?
- Kinnos was founded by Jason Kang, Kevin Tyan, Katherine Jin in 2014.
- Who are Kinnos's investors?
- Kinnos's investors include Prolog Ventures, Partnership Fund for NYC.
- How much funding has Kinnos raised?
- Kinnos has disclosed $17.3M raised across 4 rounds.
- Where is Kinnos headquartered?
- Kinnos is headquartered in Brooklyn, US.